Modulation of the microbiota across different intestinal segments by Rifaximin in PI-IBS mice

BACKGROUND: Rifaximin has been increasingly applied in irritable bowel syndrome (IBS) treatment. Whether there were differences in the effects of rifaximin on microbiota from different intestinal segments, especially the small intestine where rifaximin predominantly acted, has not been confirmed. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shengyan, Hong, Gaichao, Li, Gangping, Qian, Wei, Jin, Yu, Hou, Xiaohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850553/
https://www.ncbi.nlm.nih.gov/pubmed/36658488
http://dx.doi.org/10.1186/s12866-023-02772-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850553/
https://www.ncbi.nlm.nih.gov/pubmed/36658488
http://dx.doi.org/10.1186/s12866-023-02772-6

Ejemplares similares